Age, preoperative tumor volume and widening of the internal acoustic meatus are independent factors associated with poor preoperative hearing in vestibular schwannoma patients - results of a single-center retrospective analysis.

Autor: Dörner L; Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Hoppe-Seyler Street 3, Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany., Suhm EM; Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Hoppe-Seyler Street 3, Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany., Ries V; Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Hoppe-Seyler Street 3, Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany., Goncalves V; Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Hoppe-Seyler Street 3, Tübingen, Germany.; Faculty of Medicine, University of Porto, Porto, Portugal., Skardelly M; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.; Department of Neurosurgery, Municipal Hospital Reutlingen, Reutlingen, Germany., Schittenhelm J; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.; Department of Neuropathology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany., Tatagiba M; Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Hoppe-Seyler Street 3, Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany., Behling F; Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Hoppe-Seyler Street 3, Tübingen, Germany. felix.behling@med.uni-tuebingen.de.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany. felix.behling@med.uni-tuebingen.de.; Hertie Institute for Clinical Brain Research, Tübingen, Germany. felix.behling@med.uni-tuebingen.de.

Publikováno v: Neurosurgical review [Neurosurg Rev] 2024 Jun 08; Vol. 47 (1), pp. 262. Date of Electronic Publication: 2024 Jun 08.

Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical Trial.

Autor: Roder C; Department of Neurosurgery, University Hospital Tübingen, Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, Eberhard-Karls-University, Tübingen, Germany., Stummer W; Department of Neurosurgery, University Hospital Münster, Westphalian-Wilhelms-University, Münster, Germany., Coburger J; Department of Neurosurgery, University Hospital Ulm/Günzburg, University of Ulm, Günzburg, Germany., Scherer M; Department of Neurosurgery, University Hospital Heidelberg, Rupprecht-Karls-University, Heidelberg, Germany., Haas P; Department of Neurosurgery, University Hospital Tübingen, Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, Eberhard-Karls-University, Tübingen, Germany., von der Brelie C; Department of Neurosurgery, University Hospital Göttingen, Georg-August-University, Göttingen, Germany.; Department of Neurosurgery, Johanniter Hospital Bonn, Bonn, Germany., Kamp MA; Department of Neurosurgery, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.; Department of Neurosurgery, University Hospital Jena, Friedrich Schiller University, Jena, Germany., Löhr M; Department of Neurosurgery, University Hospital Würzburg, Julius-Maximilians-University, Würzburg, Germany., Hamisch CA; Department of Neurosurgery, University Hospital Cologne, University of Cologne, Cologne, Germany., Skardelly M; Department of Neurosurgery, University Hospital Tübingen, Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, Eberhard-Karls-University, Tübingen, Germany.; Department of Neurosurgery, Municipal Hospital Reutlingen, Reutlingen, Germany., Scholz T; Department of Neurosurgery, Asklepios Klinik Nord-Heidberg, Hamburg, Germany., Schipmann S; Department of Neurosurgery, University Hospital Münster, Westphalian-Wilhelms-University, Münster, Germany.; Department of Neurosurgery, Haukeland University Hospital Bergen, Bergen, Norway., Rathert J; Department of Neurosurgery, Helios Hospital Erfurt, Erfurt, Germany., Brand CM; Department of Neurosurgery, Municipal Hospital Dresden, Dresden, Germany., Pala A; Department of Neurosurgery, University Hospital Ulm/Günzburg, University of Ulm, Günzburg, Germany., Ernemann U; Department of Neuroradiology, University Hospital Tübingen, Eberhards-Karls-University, Tübingen, Germany., Stockhammer F; Department of Neurosurgery, Municipal Hospital Dresden, Dresden, Germany., Gerlach R; Department of Neurosurgery, Helios Hospital Erfurt, Erfurt, Germany., Kremer P; Department of Neurosurgery, Asklepios Klinik Nord-Heidberg, Hamburg, Germany., Goldbrunner R; Department of Neurosurgery, University Hospital Cologne, University of Cologne, Cologne, Germany., Ernestus RI; Department of Neurosurgery, University Hospital Würzburg, Julius-Maximilians-University, Würzburg, Germany., Sabel M; Department of Neurosurgery, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany., Rohde V; Department of Neurosurgery, University Hospital Göttingen, Georg-August-University, Göttingen, Germany., Tabatabai G; Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, German Cancer Consortium (DKTK), Partner Site Tübingen, Eberhard-Karls-University, Tübingen, Germany., Martus P; Department of Clinical Epidemiology and Applied Biostatistics, Eberhard-Karls-University, Tübingen, Germany., Bisdas S; Lysholm Department of Neuroradiology, The National Hospital for Neurology & Neurosurgery, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Ganslandt O; Department of Neurosurgery, Municipal Hospital Stuttgart, Stuttgart, Germany., Unterberg A; Department of Neurosurgery, University Hospital Heidelberg, Rupprecht-Karls-University, Heidelberg, Germany., Wirtz CR; Department of Neurosurgery, University Hospital Ulm/Günzburg, University of Ulm, Günzburg, Germany., Tatagiba M; Department of Neurosurgery, University Hospital Tübingen, Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, Eberhard-Karls-University, Tübingen, Germany.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Dec 20; Vol. 41 (36), pp. 5512-5523. Date of Electronic Publication: 2023 Jun 19.

Distribution of the immunohistochemical expression of BAP1 in meningiomas

Autor: Behling, F, Fodi, C, Skardelly, M, Schittenhelm, J, Honegger, JB, Tabatabai, G, Tatagiba, M, Beschorner, R

Publikováno v: 73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie; 20220529-20220601; Köln; DOCP120 /20220525/

Objective: Meningiomas are mostly benign tumors arising from the arachnoid cap cells. However, prognostic assessment is important to identify cases with a tendency for a more aggressive behavior. The loss of the breast cancer (BRCA)1-associated prote

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fee53a74a1d4292903feb91afc837dac

Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.

Autor: Wang JZ; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Patil V; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Liu J; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Dogan H; Department of Neuropathology, University Hospital Heidelberg (DKFZ), Heidelberg, Germany., Tabatabai G; German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany.; Department of Neurology and Interdisciplinary Neuro-Oncology, Center for Neuro-Oncology, Comprehensive Cancer Center, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany., Yefet LS; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada., Behling F; Department of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany., Hoffman E; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University Tübingen, Tübingen, Germany., Bunda S; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Yakubov R; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Kaloti R; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Brandner S; Division of Neuropathology, UCL Queen Square Institute of Neurology, London, UK., Gao A; Division of Laboratory Medicine and Pathobiology, University Health Network, Toronto, ON, Canada., Cohen-Gadol A; Department of Neurosurgery, Indiana University, Bloomington, IND, USA., Barnholtz-Sloan J; Division of Cancer Epidemiology and Genetics, Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health, Gaithersburg, MD, USA., Skardelly M; Department of Neurology and Interdisciplinary Neuro-Oncology, Center for Neuro-Oncology, Comprehensive Cancer Center, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany., Tatagiba M; Department of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany., Raleigh DR; Department of Radiation Oncology, Neurological Surgery, and Pathology, University of California San Francisco, San Francisco, CA, USA., Sahm F; Department of Neuropathology, University Hospital Heidelberg (DKFZ), Heidelberg, Germany., Boutros PC; Department of Human Genetics, University of California Los Angeles (UCLA), Los Angeles, CA, USA., Aldape K; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Nassiri F; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada. farshad.nassiri@mail.utoronto.ca.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada. farshad.nassiri@mail.utoronto.ca.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. farshad.nassiri@mail.utoronto.ca., Zadeh G; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada. gelareh.zadeh@uhn.ca.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada. gelareh.zadeh@uhn.ca.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. gelareh.zadeh@uhn.ca.

Publikováno v: Acta neuropathologica [Acta Neuropathol] 2023 Jul; Vol. 146 (1), pp. 171-172.

The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma.

Autor: Fodi C; Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Hoppe-Seyler Street 3, Tübingen, Germany.; Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany., Skardelly M; Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Hoppe-Seyler Street 3, Tübingen, Germany.; Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany., Hempel JM; Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.; Department of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany., Hoffmann E; Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.; Department of Radiation-Oncology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany., Castaneda S; Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.; Department of Nuclear Medicine, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany., Tabatabai G; Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Hoppe-Seyler Street 3, Tübingen, Germany.; Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.; Hertie Institute for Clinical Brain Research, Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany., Honegger J; Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Hoppe-Seyler Street 3, Tübingen, Germany.; Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany., Tatagiba M; Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Hoppe-Seyler Street 3, Tübingen, Germany.; Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany., Schittenhelm J; Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.; Department of Neuropathology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany., Behling F; Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Hoppe-Seyler Street 3, Tübingen, Germany. felixbehling@yahoo.de.; Center for CNS Tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany. felixbehling@yahoo.de.; Hertie Institute for Clinical Brain Research, Tübingen, Germany. felixbehling@yahoo.de.

Publikováno v: Neurosurgical review [Neurosurg Rev] 2022 Aug; Vol. 45 (4), pp. 2671-2679. Date of Electronic Publication: 2021 Oct 02.